Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PYGB | P11216 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | THRB | P10828 | 1/20 | 0.41 |
| ▸ | LGALS8 | O00214 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | KDR | P35968 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.38 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.38 |
| ▸ | SYNJ2 | O15056 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17918898 | 0.88 | ALDH1A1 (0.44) | PYGBALDH1A1THRBLGALS8L3MBTL1 | |
| SCHEMBL17919043 | 0.83 | ALDH1A1 (0.43) | PYGBALDH1A1THRBLGALS8L3MBTL1 | |
| SCHEMBL17918953 | 0.80 | SYNJ2 (0.46) | PYGBLGALS8KDRMAPTSYNJ2 | |
| SCHEMBL23867560 | 0.78 | PYGB (0.51) | PYGBLGALS8L3MBTL1MAPTSLC28A3 | |
| SCHEMBL642397 | 0.78 | PYGB (0.51) | PYGBLGALS8L3MBTL1MAPTSLC28A3 | |
| SCHEMBL4394977 | 0.78 | PYGB (0.51) | PYGBLGALS8L3MBTL1MAPTSLC28A3 | |
| SCHEMBL17919001 | 0.77 | SELP (0.48) | PYGBLGALS8MAPTSYNJ2 | |
| SCHEMBL2346599 | 0.77 | SELL (0.46) | PYGBALDH1A1THRBMAPK1 | |
| SCHEMBL7211096 | 0.76 | PYGB (0.53) | PYGBALDH1A1THRBLGALS8L3MBTL1 | |
| SCHEMBL29217350 | 0.76 | PYGB (0.50) | PYGBALDH1A1THRBLGALS8L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160200755-A1 | GLYCOAMINO ACID AND USE THEREOF | AJINOMOTO CO., INC. (JP) | 2016-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160200755-A1 | GLYCOAMINO ACID AND USE THEREOF | GYPA, NGLY1, SLC6A15 | PYGB 624/4885ALDH1A1 1637/4885THRB 2264/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.